Carthyal® is a line of products for Osteoarthritis.
Carthyal® Injectables are hyaluronic acid (HA) intraarticular injections, in some cases in association with other compounds, that can replace the synovial fluid and are indicated in the prevention and treatments of trauma-caused and degenerative diseases in synovial joints.
Carthyal® ONE is a unique combination of cross-linked hyaluronic acid, intercalated with linear hyaluronic acid, with a total molecular weight of 1.000.000 Da + 2.000.000 Da (cross linked HA fraction) + 500.000 Da (linear HA faction). The product delivers 75mg of HA in a 3ml sterile syringe.
MAIN INGREDIENTS
Hyaluronic Acid
PRESENTATION
Box with a labeled 3 ml syringe, packed in a syringe case with leaflet.
HOW TO USE
Treatment with 1 injection every 6 to 12 months.
PRODUCT ADVANTAGES
1 Single injection treatment.
Immediate action by reducing the pain and inflammation Highly effective restoration of the viscoelastic properties of the joints’ synovial fluid Improvement of the articular mobility, with functional recovery of the joint Prevention the natural degradation of the joints Safe, widely document treatment with less side effect
OTHER INFORMATION
Medical Device Class III. Produced in Europe under ISO 13485.
Hyaluronic acid, CHONDROITIN SULPHATE AND CYCLODEXTRIN intraarticular injections
Carthyal® is a line of products for Osteoarthritis.
Carthyal® Injectables are hyaluronic acid (HA) intraarticular injections, in some cases in association with other compounds that can replace the synovial fluid and are indicated in the prevention and treatments of trauma-caused and degenerative diseases in synovial joints.
Carthyal® Chondro has a unique composition of 60 mg of linear Hyaluronic Acid + 60mg of Chondroitin Sulphate and 30mg of Hydroxypropyl beta-Cyclodextrin, with a high molecular weight from 2.800.000 to 3.500.000 Da, packed in a 3ml sterile syringe.
MAIN INGREDIENTS
Hyaluronic Acid, Chondroitin Sulphate And Cyclodextrin.
PRESENTATION
Box with a labeled 3 ml syringe, packed in a syringe case with leaflet.
HOW TO USE
Treatment with 1 injection every 6 to 12 months.
PRODUCT ADVANTAGES
1 Single injection treatment.
Immediate action by reducing the pain and inflammation.
Highly effective restoration of the viscoelastic properties of the joints’ synovial fluid.
Improvement of the articular mobility, with functional recovery of the joint.
Prevention the natural degradation of the joints.
Safe, widely document treatment with less side effect.
OTHER INFORMATION
Medical Device Class III. Produced in Morocco under ISO 13485.
36 months shelf life.
Carthyal® Daily Care
Dietary supplement
Carthyal® is a line of products for Osteoarthritis.
Carthyal® Daily Care is a dietary supplement with Glucosamine, Chondroitin, Boswellia, MSM and Vitamin C.
Carthyal® Daily Care contains 600 mg of glucosamine sulfate; 600 mg of chondroitin sulfate; 350 mg of MSM (methylsulfonylmethane); 100 mg of Boswellia and 80 mg of vitamin C in 2 tablets, promoting joint mobility and comfort.
Carthyal® Daily Care can be used in concomitance with other treatments, such as Carthyal ® injectables or alone, as a way to delay the progression of the osteoarthritis in patients with light to moderate symptoms.
